Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.81 USD | -0.68% | +14.57% | -21.38% |
05-09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.38% | 629M | |
+7.30% | 113B | |
+11.01% | 106B | |
+0.96% | 22.27B | |
-12.19% | 22.22B | |
-5.52% | 19.43B | |
-37.85% | 17.87B | |
-5.99% | 17.24B | |
+7.05% | 14.29B | |
+34.83% | 12.52B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- B. Riley Raises Altimmune's PT to $20 From $15 on Increased Obesity+NASH Therapeutics' Product Sales Projections; Keeps Buy Rating